Skip to content
10-Q

Quarterly Report

GFR PHARMACEUTICALS INC

0001437749-11-005893

← back to feed
Filed
Aug 12, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Aug 10, 2011 42.08M sh
Shares Diluted Q2 2011 · Jun 30, 2011 42.08M sh
Shares Diluted Q2 2011 · Jun 30, 2011 42.08M sh
Shares Diluted Q2 2011 · Jun 30, 2010 42.08M sh
Shares Diluted Q2 2011 · Jun 30, 2010 42.08M sh
Stockholders Equity Q2 2011 · Jun 30, 2011 $7.51M
Stockholders Equity Q2 2011 · Dec 31, 2010 $6.36M
Current Liabilities Q2 2011 · Jun 30, 2011 $980.75K
Current Liabilities Q2 2011 · Dec 31, 2010 $1.05M
Total Liabilities Q2 2011 · Jun 30, 2011 $1.81M
Total Liabilities Q2 2011 · Dec 31, 2010 $1.86M
Current Assets Q2 2011 · Jun 30, 2011 $1.36M
Current Assets Q2 2011 · Dec 31, 2010 $1.72M
Total Assets Q2 2011 · Jun 30, 2011 $9.96M
Total Assets Q2 2011 · Dec 31, 2010 $8.82M
Capex Q2 2011 · Jun 30, 2010 $277.99K
Operating Cash Flow Q2 2011 · Jun 30, 2010 $576.26K
Cash And Equivalents Q2 2011 · Jun 30, 2010 $398.95K
Cash And Equivalents Q2 2011 · Dec 31, 2009 $55.49K
Sga Expense Q2 2011 · Jun 30, 2010 $94.71K
Sga Expense Q2 2011 · Jun 30, 2010 $266.16K
Net Income Q2 2011 · Jun 30, 2010 $862.54K
Net Income Q2 2011 · Jun 30, 2010 $1.13M
Operating Income Q2 2011 · Jun 30, 2010 $844.49K
Operating Income Q2 2011 · Jun 30, 2010 $1.26M
Gross Profit Q2 2011 · Jun 30, 2010 $985.28K
Gross Profit Q2 2011 · Jun 30, 2010 $1.63M
Cost Of Revenue Q2 2011 · Jun 30, 2010 $200.95K
Cost Of Revenue Q2 2011 · Jun 30, 2010 $350.89K